50
Participants
Start Date
October 10, 2025
Primary Completion Date
April 30, 2026
Study Completion Date
May 30, 2026
Monarch RAB with CBCT-guided ICG Dye Marking
Under general anesthesia, the Monarch RAB platform is used to navigate to the target bronchus. With CBCT confirmation, 0.25 ml of ICG (0.2 mg/ml) mixed with 0.25 ml iodinated contrast is injected within 1 cm of the nodule. The dye marking is identified intraoperatively with near-infrared light to guide VATS sublobectomy.
Peking University Cancer Hospital & Institute
OTHER